Try our Advanced Search for more refined results
Life Sciences - November, 2024
222 articles
- A Look Back At Years Of Zantac Litigation: Timeline
- PTAB Finds Hormone Treatment Patent Claims Invalid
- Deloitte Posed As Consultant To Steal Vax Software, Suit Says
- PBM Says Opioid Ruling Ignored High Court's Privilege Stance
- Nonprofit Warns 3rd Circ. Against 'Abuse' In Merck Vax Case
- Amid Claims Of Bias, DEA To Kick Off Historic Pot Hearing
- Dissecting The Obviousness-Type Double Patenting Debate
- Up Next At The High Court: Transgender Care, Holocaust Art
- Hospital Sued For Firing Tech Who Reported Lax Drugmaking
- Service Providers Must Mitigate 'Secondary Target' Risks
- Congressional Dems Urge Biden For More Cannabis Reform
- Trump Taps Bhattacharya For National Institutes Of Health
- NIH Beats 4th Circ. Bid To Unmask COVID Researcher
- Beasley Allen Escapes Sanctions For J&J Deposition No Show
- Gilead Gets $31.8M In Calif. Case Over Counterfeit HIV Drugs
- Health Policy Predictions For Trump's Second Administration
- FDA Seeks Fines Against 18 Retailers Over E-Cig Sales
- Court Asked To Halt DEA's Pot Rescheduling Hearing
- Paul Hastings Seeks GenapSys CEO Depo In Malpractice Suit
- Flying Makes Me A Better Lawyer
- Navajo Nation's Diné College Awarded 2nd Medical Patent
- Mexico Floats Retaliation Against New Trump Tariffs
- Ex-Regeneron Director Says FMLA Suit Should Stay In Court
- 9th Circ.'s High Bar May Limit Keyword Confusion TM Claims
- Trump Vows Tariffs For Canada, Mexico, China On Day One
- Calif. Jury Delivers $35M Verdict In Eyedrop Trademark Row
- Calif. Panel Scraps Ex-Medical Supply Exec's $533K Fee Win
- DEA And Anti-Pot Group Reject Accusations Of Collusion
- Medical Info. Co. Beats Junk Fax Suit Over Free E-Book Offer
- Trump Patent Policy May Be Headed In Unexpected Direction
- Jury Finds Natera Owes Guardant $292.5M In False Ad Suit
- Ex-Epstein Becker Healthcare Ace Joins Polsinelli Team
- MVP: Cooley's Lila Hope
- What Trump's Next Term May Mean For Biz Immigration
- Trump Makes Picks For FDA, CDC And Surgeon General
- Natera's Conduct 'Despicable,' Guardant Says As Trial Wraps
- Pam Bondi's 'Greatest Hits' As Florida Attorney General
- CooperSurgical Product Caused Embryo Loss, Couple Say
- Mich. Justices Want To Know If 3M Water Challenge Is Moot
- Bondi Vowed Trump Payback. Ex-Colleagues Aren't Worried.
- Racing Patents To The Fed. Circ.: Collateral Estoppel Lessons
- Vitamin Co. Must Freeze Owner Payouts Amid $1.4M Tax Fight
- Walmart Class Attys In $123M Opioid Deal Seek $24.6M Fee
- Avante Health Parent Cleared To Sell For $72.5M In Ch. 11
- Halozyme Pulls €2B Bid After Evotec Fails To Engage In Talks
- MVP: Skadden's Graham Robinson
- UK Litigation Roundup: Here's What You Missed In London
- Circus Arts Make Me A Better Lawyer
- SEC Denied Civil Penalties Over Pot Pill Exec's 'Inexperience'
- Boehringer Trial Over Zantac's Cancer Link Ends In Mistrial
- SEC Seeks More Data On Nasdaq Plan To Speed Up Delistings
- Trump Selects Ex-Fla. AG Pam Bondi As New AG Pick
- IP Atty Fights To Revive Allergan FCA Suit At 9th Circ.
- In Tight Vote, Senate Panel OKs Bill To Set New PTAB Limits
- 3 Ways To Train Junior Lawyers In 30 Minutes Or Less
- MVP: Fenwick's Douglas Cogen
- Musk, Ramaswamy Say High Court Rulings OK Federal Cuts
- Ex-Pharma CEO Demands Legal Fees For SEC Probe
- USPTO Unveils Patent Fee Hikes Set To Take Effect In January
- DEA Accused Of Colluding With Reform Foes In Pot Row
- How AstraZeneca Ruling Could Change Dosage Patent Claims
- PBMs Sue To Block FTC's In-House Insulin Pricing Case
- 3 States To Challenge Abortion Regs After Docs Drop Claims
- Beasley Allen And J&J Tussle Over Atty Sanctions Bid
- Weil Litigation Leaders Jump To Paul Weiss In NY
- MVP: Williams & Connolly's David I. Berl
- Pfizer Unit Can't Get $75M Left In Insider Trading Deal Fund
- High Court Urged To Let Courts Scrutinize Agency Rulings
- DC Circ. Wonders Where To Land On Terrorism Liability Claims
- Blood Vessel Maker Faces Investor Suit Over FDA Findings
- Costco Shoppers Say Kirkland Fish Oil Pills Hide Heart Risks
- Calif. Biotech Firm Vera Taps Veteran Chief Legal Officer
- 10th Circ. Iffy On Colo.'s Remedy To Generic EpiPen Takings
- Failed W.Va. Patent Challenge Reveals Secret Prior Art's Risks
- J&J Wants Beasley Allen Atty Sanctioned For Depo No-Show
- Navigating Decentralized Clinical Trials With FDA's Guidance
- McGuireWoods Lands Health Ace, Former GC From Akin In NY
- Akin Adds Another Healthcare Expert To DC Lobbying Team
- MVP: Covington's Catherine Dargan
- The Bar Needs More Clarity On The Discovery Objection Rule
- McDermott Adds IP Pro From Gibson Dunn In Los Angeles
- 'You Stepped Over The Line': Judge Rips Quinn Emanuel Atty
- J&J Posts $1.17B Bond For Del. Merger Milestone Appeal
- Melinta Obtains Ban On Generic Antibiotic Injections In IP Row
- Pa. Lab Seeks Ad Coverage For Libel Suit Over COVID Tests
- $100M Deal In Suit Over Walgreens Rx Prices Gets First OK
- Medical Group Wants Justices To Review IP Safe Harbor Fight
- Biopharm Co. Seelos Files For Ch. 11 After Nasdaq Delisting
- How Patent Landscape Analysis Drives Business Growth
- MVP: Ropes & Gray's Amanda Austin
- Supreme Court Turns Down 3 Patent Cases
- Eli Lilly Says HHS Ignores Drug Discount Double-Dipping
- Natera Exec Calls Guardant's Cancer Test Claims 'Dangerous'
- SEC-Sanctioned Accounting Firm Sued Over Pre-IPO Work
- PBMs Denied Breakup Of Combined FTC Insulin Price Trial
- Despite Vaccine Spotlight, RFK Jr. A Health Policy 'Unknown'
- Ariz. Judge Will Decide Proper Venue For CVS Antitrust Suit
- DEA Judge Nixes Vet Group's Bid To Take Part In Pot Hearings
- In Terror Case, DC Circ. Must Weigh Justices' Twitter Ruling
- Marching In On Orange Book Drugs May Have Limited Effect
- Abbott Inks $8M Deal With Healthcare Fraudster In TM Suit
- Ayahuasca Church Urges Justices To Hear Discovery Case
- Teva Defends Mifepristone Antitrust Case Against Corcept
- Attys Get 'Final Warning' In Tepezza Hearing Loss MDL
- HOA's Insurer Says Pool Chemical Injury Suits Aren't Covered
- Being A Navy Reservist Makes Me A Better Lawyer
- Orrick Trial Partner Joins Morgan Lewis In Boston
- Pharma Biz To Pay $47M To Settle Feds' Kickback Claims
- Sterilization Co. Cosmed Hits Ch. 11 Amid Cancer Claims
- Trump's RFK Jr. Pick For HHS Draws Its Share Of Critics
- Senate Panel Delays Votes On Patent Eligibility And PTAB Bills
- Judge Finds Dexcom Infringed Abbott Patent That Hung Jury
- Takeda Rips Cert. Order's 'Whale Of Assumption' At 9th Circ.
- Incoming Admin May Shake Up Life Sciences Regulation
- Boehringer Says Inhaler Antitrust Suit 'Fails On Its Face'
- Next Steps In The $2.8B Blue Cross Payout To Providers
- Boeing Could Sell Navigation Unit For $6B, And More Rumors
- Trump Picks RFK Jr. To Lead Health & Human Services
- So You Want To Move Your Law Practice To Canada, Eh?
- Guardant Atty Accuses Natera CEO Of Dishonesty At Trial
- Damages Limited In AGs' Generic Drug Price-Fixing Case
- Honey Pot Greenwashes 'Plant-Derived' Products, Suit Says
- Ozempic MDL Plaintiffs Say Eli Lilly, Novo Nordisk Hid Risks
- Alnylam Says It's Not A 'Patent Troll' In Vax IP Row
- TikTok Asks To Keep NC AG's Addiction Complaint Redacted
- Baltimore Wins $266M In McKesson, Cencora Opioid Case
- Biotech Brass Misled Investors About Cancer Drugs, Suit Says
- What To Expect Next From Federal Health Tech Regulation
- Trump's Choice Of Matt Gaetz For AG Hints At Cannabis Policy
- Trump Rollback Of Biden Enviro Policies: What To Expect
- Trump Taps Elon Musk To Head New 'Gov't Efficiency' Dept.
- Masimo Can't Tie Alleged IP Theft To Apple Profits, Expert Says
- Guardant CEO Says Rival's False Ads Hurt 'Beautiful Baby'
- Justices Told Fed. Circ. Overstep Claims Are 'Simply Incorrect'
- HIV Drug Buyers Want Gilead Product Switch Claims Revived
- J&J Says HHS Is Thwarting Transparency Of Drug Discounts
- Elanco Pays $15M SEC Fine To Settle Sales Incentive Claims
- GOP Reps. Propose Another Bill On TRIPS Waivers
- Unsatisfied With $70M UTC Win, Sandoz Appeals To 3rd Circ.
- Takeaways From State Votes On Abortion In The 2024 Election
- Key Territory-Split Licensing Lessons For Life Sciences Cos.
- Feds Can Hold Proceeds During Chinese Syringe Duties Fight
- DOJ Suing To Block UnitedHealth Unit's $3.3B Amedisys Deal
- Legislation Most Likely To Pass In Lame Duck Session
- NJ Ethics Board Escapes Contempt Bid In Retaliation Fight
- Apple Didn't Hire Cercacor CTO To Steal Watch IP, Ex-VP Says
- 5th Time Not The Charm For 'Stale' Dow Implant Check Fight
- J&J Talc Unit Must Revise Ch. 11 Plan, Insurers Say
- Fed. Circ. Unclear If Teva Inhaler IP Belongs In Orange Book
- Ill. Judge Sends Abbott Safety Gear OT Suit To Ohio
- Ex-Elanco IP Lawyer Lodges Gender Discrimination Suit
- Judge Lets Plaintiffs Drop Kroger Pain Patch Suit
- Justices Must Weigh Reach Of Civil RICO In Cannabis Case
- White & Case Adds Life Sciences IP Atty From A&O Shearman
- Litigation Strategies In View Of New Double Patenting Rulings
- Promoting Diversity In The Selection Of ADR Neutrals
- Wuhan Chemical Co. Charged In Latest China Fentanyl Bust
- Teva Fails To Convince Judge Inhaler Patents Require Drug
- Masimo Spinoff's Ex-CTO Denies Giving Apple Trade Secrets
- Ex-Natera VP Defends Ad Campaign Against Rival Guardant
- 3rd Circ. Says Tainted Bayer Antifungals Clearly 'Worth Less'
- FDA Wants Ineffective Decongestant Removed From Market
- Ill. Judge Anticipates 'Massive' Outcome Investor Restitution
- Researcher Sues DEA Over Pot Rescheduling Process
- Eye Drop Maker To Pay $3.6M To Settle Class Claims
- Teva Can't End Inhaler Antitrust Suit But Gets Claim Nixed
- Same PBM Conduct Means Same Insulin Price Trial, FTC Says
- Playing Ultimate Makes Us Better Lawyers
- LeBron Eyes Media Merger, AI Startup IPO, And More Rumors
- Masimo Expert Cites LED And Foam As Evidence Apple Stole IP
- Natera Declared 'War' On Guardant, Jury Told At Trial's Start
- Trump's Win Likely To Spur Deals For Capital Markets Attys
- After Electoral Defeats, Cannabis Advocates Eye Next Steps
- Sanctioned Supplier, Abbott Strike Deal Over TM Judgment
- Medtronic Says Axonics Misled Jury To Beat Patent Case
- Feds Fight Philly Injection Site Group's 3rd Circ. Appeal
- Insurers Urge Del. Justices To Reverse Drug Co. Policy Ruling
- Feds Look To Halt Vitamin Co. Payouts Amid $1.4M Tax Fight
- Business Groups Urge Calif. Justices To Nix HIV Drug Ruling
- What A Second Trump Term Could Mean For FDA And CPSC
- E-Discovery Quarterly: Recent Rulings On Metadata
- Tobacco Cos. Side With FDA In Menthol Cigarette Ban Fight
- How The Patent System May Look After Trump's Return
- Trump Has Official Immunity. What About His Aides?
- How Trump Can Quash His Criminal Cases
- An Early Look At Trump's Supreme Court Shortlist
- GOP's Senate Win Hands Future Of The Judiciary To Trump
- The Firms With An Inside Track To A New Trump Admin
- Cannabis And Psychedelic Reform Bids Fail In Multiple States
- Wash. AG With Antitrust Focus Wins Governor's Race
- Apple Stole Masimo Sensor IP, Calif. Judge Told At Trial's Start
- Eye-Rolling Must Stop, Judge Warns Before False Ad Trial
- Target Inks Individual Deals Over 'Non-Drowsy' Flu Medicine
- Thermo Fisher Antitrust Counsel Returns To Ropes & Gray
- Lab Owner's Atty DQ'd After Repping Doctor In Fraud Inquiry
- McDermott Lands Pharma IP Attorney From DLA Piper In SF
- On The Ground: How Attorneys Safeguarded The Election
- Abortion Ballot Tracker: 7 States Add Protections As Fla. Effort Fails
- Kroger, State AGs Finalize Sprawling $1.37B Opioid Deal
- Whistleblowers Win Cut Of Medical Kickback Settlement
- Sanctions Lessened Against Testing Co. That 'Duped' Judge
- Startup Beats $460M Cancer Trade Secrets Case In Delaware
- Del. Judge To Approve Avante Ch. 11 Financing
- Cigna Scores $7.3M Verdict Against Fla. Drug Testing Labs
- Late New Evidence Can't Revive Investor Suit, Judge Says
- Yale Gets 2nd Circ. Win In COVID Test Reimbursement Row
- Errors Lower Fee Award For Athira Pharma Investors' Counsel
- NJ Judge Blocks Sun Pharma From Launching Hair Loss Drug
- Sandoz Wins $70M In Antitrust Suit Over Hypertension Drug
- Federal Trade Commission Atty Returns To Katten In DC
- PREVAIL Bill Is Another Misguided Attempt To Restrict PTAB
- Striking A Balance Between AI Use And Attorney Well-Being
- US IPO Activity Hits Standstill As Election Takes Center Stage
- Medisca Inks $22M FCA Deal Over Ingredient Pricing Scheme
- UChicago Must Face Student's Disability Discrimination Claim
- Jury To Decide Timing Issue In Insulin Patch Trade Secret Row
- Taxation With Representation: Kirkland, Davis Polk, Wachtell
- UK Litigation Roundup: Here's What You Missed In London
- Empathy In Mediation Offers A Soft Landing For Disputes
- Up To $755M Added To AZ Scuttled-Drug Damage Claim In Del.
- Being An Artist Makes Me A Better Lawyer
- 4 States To Vote On Expanding Cannabis Or Psychedelics